HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Preventative effects of lactulose in the trinitrobenzenesulphonic acid model of rat colitis.

AbstractAIMS:
Lactulose is a drug used as a laxative that has been shown to promote the growth of lactobacilli and bifidobacteria, acting as a prebiotic and with a potential beneficial effect in inflammatory bowel disease. The present study describes the preventive antiinflammatory activity of lactulose in the trinitrobenzenesulphonic acid (TNBS) model of rat colitis.
METHODS:
Rats were rendered colitic by a colonic instillation of 10 mg of TNBS dissolved in 0.25 mL of 50% ethanol. One group of colitic rats received lactulose, which was incorporated in the drinking water (2.5% wt/vol) for 2 weeks before TNBS instillation, and colonic damage was evaluated 1 week after colitis induction. Different biochemical markers of colonic inflammation were assayed: myeloperoxidase activity, glutathione content, tumor necrosis factor alpha, leukotriene B4 levels, and colonic inducible nitric oxide synthase expression. In addition, bacterial counts (for lactobacilli and bifidobacteria) were performed in colonic contents from colitic rats.
RESULTS:
The results show that lactulose exerted a preventive antiinflammatory effect in this model of rat colitis, as evidenced by a significant reduction of myeloperoxidase activity and by a decrease of both colonic tumor necrosis factor alpha and leukotriene B4 production. This effect was also characterized by an inhibition of colonic inducible nitric oxide synthase expression, which is unregulated as a consequence of the inflammatory status. This beneficial effect was associated with increased levels of lactobacilli and bifidobacteria species in colonic contents in comparison with untreated colitic rats.
CONCLUSION:
In conclusion, the intestinal antiinflammatory effect of lactulose could be related to its prebiotic properties, supporting its potential use in human inflammatory bowel disease.
AuthorsDesiree Camuesco, Laura Peran, Monica Comalada, Ana Nieto, Luiz C Di Stasi, M Elena Rodriguez-Cabezas, Angel Concha, Antonio Zarzuelo, Julio Galvez
JournalInflammatory bowel diseases (Inflamm Bowel Dis) Vol. 11 Issue 3 Pg. 265-71 (Mar 2005) ISSN: 1078-0998 [Print] England
PMID15735433 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Gastrointestinal Agents
  • Tumor Necrosis Factor-alpha
  • Leukotriene B4
  • Lactulose
  • Trinitrobenzenesulfonic Acid
  • Peroxidase
Topics
  • Animals
  • Colitis (drug therapy, prevention & control, veterinary)
  • Disease Models, Animal
  • Female
  • Gastrointestinal Agents (pharmacology)
  • Lactobacillaceae (growth & development)
  • Lactulose (pharmacology)
  • Leukotriene B4 (biosynthesis)
  • Peroxidase (pharmacology)
  • Rats
  • Rats, Wistar
  • Trinitrobenzenesulfonic Acid (administration & dosage, adverse effects)
  • Tumor Necrosis Factor-alpha (biosynthesis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: